BioNTech profits soar in 2021 on global vaccine rollout

German vaccine-maker BioNTech on Wednesday reported a multi-billion-euro windfall in 2021 from sales of its anti-coronavirus jab, developed together with US pharmaceutical giant Pfizer.

source https://medicalxpress.com/news/2022-03-biontech-profits-soar-global-vaccine.html